Advicenne announces commercialization agreement with FrostPharma AB for Sibnayal™ in the Nordic region Advicenne announces commercialization agreement with FrostPharma AB for Sibnayal™ in the Nordic region Advicenne will receive a transfer price and royalties for an amount markedly higher than 50%...

Advicenne provides an update on its activities following its Annual General Meeting Advicenne provides an update on its activities followingits Annual General Meeting Introducing Advicenne 2.0, the Company’s strategy to unlock valuePoised to partner Sibnayal in dRTA in Europe...